VeriMomginsenoside rg4 é seguro durante a gravidez?
No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).
Related ingredients
Frequently asked questions
- ginsenoside rg4 é seguro durante a gravidez?
- No harmonised CLP classification, SCCS opinion, or CIR safety assessment for ginsenoside Rg4 was found, and no animal or human reproductive/toxicology data specific to Rg4 indicating developmental or teratogenic effects were located in the searched literature. Identity/compound records (PubChem/supplier pages) confirm this is a high‑molecular‑weight ginsenoside (low likelihood of systemic reproductive hazard at cosmetic topical use). Sources: PubMed searches for reproductive effects found studies on other ginsenosides (e.g., Rg1, Rb1) but not Rg4; no authoritative safety assessment listing Rg4 as repro‑toxic. (PubChem/supplier records; PubMed; EWG).
- ginsenoside rg4 é seguro durante a amamentação?
- No evidence was found that Rg4 is classified for reproductive or lactation hazard, and no studies showing transfer into milk or lactation toxicity for Rg4 were identified. By the priority rules, absence of CIR/SCCS/harmonised flags and lack of Rg4‑specific lactation data leads to default low hazard and mechanism scores. (Sources: PubChem/supplier pages; literature search on PubMed; EWG ingredient summary).
- ginsenoside rg4 é seguro para a pele do bebê?
- No infant‑specific toxicity data for Rg4 were identified. Dermal exposure assessment: Rg4 is a large, polar glycoside (MW ~767) typical of ginsenosides; such molecules have low dermal permeability, so adult topical exposure is likely negligible (e=0). However, given immature infant barrier and instruction in scoring, exposure for baby skin is increased by +1 to e=1 in absence of infant data. No infant dermal adverse effects or studies were found. (Sources: PubChem/supplier data on structure/MW; lack of reproductive/infant studies on PubMed; EWG ingredient page).
- Como o VeriMom pontua ginsenoside rg4?
- O VeriMom pontua ginsenoside rg4 em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a ginsenoside rg4 na gravidez?
- Veja nossa lista curada de alternativas seguras a ginsenoside rg4 com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.